Activation of a distinct subpopulation of pulmonary macrophages following exposure to biological response modifiers

D B Drath1, C Do, T Burd

  • 1Department of Biological Science, California State University, Fullerton 92634.

Insights

Lung macrophages can be activated to kill tumors using biological modifiers like N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) and interferon-gamma (IFN-gamma). These activated macrophages also release oxygen free radicals, indicating metabolic activation.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Pulmonary macrophages play a crucial role in immune responses within the lungs.
  • Understanding macrophage activation is key to developing novel cancer therapies.

Purpose of the Study:

  • To investigate the tumoricidal capabilities of different pulmonary macrophage populations.
  • To explore the efficacy of various biological response modifiers in activating these macrophages.
  • To assess the metabolic activation of macrophages through superoxide radical release.

Main Methods:

  • In vitro and in vivo activation of tissue-associated pulmonary macrophages (TAPM) and alveolar macrophages.
  • Treatment with N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), 6-O-stearoyl MDP (S-MDP), and recombinant interferon-gamma (IFN-gamma).
  • Assessment of tumoricidal activity against syngeneic, xenogeneic, and allogeneic targets.
  • Evaluation of in vivo activation via different delivery methods (intravenous, osmotic minipump, intratracheal).
  • Measurement of superoxide free radical release as an indicator of metabolic activation.

Main Results:

  • A subpopulation of TAPM exhibited tumoricidal activity after MDP incubation.
  • Both TAPM and alveolar macrophages demonstrated tumoricidal activity upon incubation with S-MDP or IFN-gamma.
  • Intravenous or osmotic minipump delivery of IFN-gamma was most effective for in vivo activation.
  • Liposome-encapsulated S-MDP also induced in vivo activation.
  • Metabolic activation, indicated by superoxide release, occurred after exposure to S-MDP or lipopolysaccharide, enhanced by liposomal incorporation.

Conclusions:

  • Pulmonary macrophages, particularly a subpopulation of TAPM, can be activated to a tumoricidal state.
  • Biological response modifiers like MDP derivatives and IFN-gamma are effective in inducing this activation.
  • Macrophage activation is associated with the release of oxygen free radicals.
  • Delivery methods significantly impact the efficacy of in vivo macrophage activation.